J&J vaccine pause a sign of ‘super cautious’ health agencies
Federal health agencies have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six people developed blood clots within two weeks of receiving the one-shot vaccine. Government professors Sarah Kreps and Doug Kriner, who have surveyed nearly 2,000 American adults on issues regarding their willingness to get a vaccine, comment.